Venous thrombosis

Syndicate content

Deep venous thrombosis new treatment may improve outcomes

Deep Venous Thrombosis is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with Deep Venous Thrombosis is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).

Get the full story...

Thrombosis patients face greater risks than previously believed

Deep venous thrombosis (DVT), the formation of blood clots in the lower limbs, is the third-most common vascular disease in North America after heart attack and stroke, and is a frequent complication in hospitalized patients.

Get the full story...

Risk factors of abdominal venous thrombosis

Abdominal venous thrombosis may present as BCS or SVT. Hereditary and acquired risk factors have been implicated in the etiopathogenesis of abdominal venous thrombosis.

Get the full story...

1 in 5 patients receive treatment to prevent life-threatening blood clots

Fewer than 1 in 5 patients received post-discharge therapy to prevent life-threatening blood clots — venous thrombosis — after hip- or knee-replacement surgery, report Rahme and colleagues in a retrospective cohort study. Venous thrombosis is one of the leading causes of death among hospital patients. However, elderly patients have a 70% lower chance of dying within 3 months if they take an anticoagulant drug to prevent blood clots.

Get the full story...

Risk of venuous thrombosis in long-haul flights

In a paper published this week in the open-access journal PLoS Medicine Frits Rosendaal and colleagues from Leiden University Medical Center, Academic Medical Center Amsterdam and Nestlй Medical Services, provide the first absolute estimate of risk of venous thrombosis after air travel.

Get the full story...

Identifying markers for menopausal women at risk for deadly blood clot

In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein. Despite the fact that the disorder is rare, it increases exponentially during menopause and can be deadly. The hormone trials conducted thus far, focusing on proteins in blood coagulation, have not yet led to a risk profile, thereby precluding identification of women at risk.

Get the full story...

Venous thromboembolism risk among hospitalized patients

Venous thrombosis (VTE), the formation of blood clots in a vein, is a major health problem for hospitalized patients in the United States. In the short term, VTE can lead to deep vein thrombosis (DVT), typically in the legs, and pulmonary embolism (PE), which occurs when a piece of the blood clot migrates into an artery of the lungs.

Get the full story...